ACN vs PALI · P/E 24, rev $17.60B vs P/E 15, rev $500.0K
Accenture plc (ACN) versus Palisade Bio Inc (PALI) — a side-by-side from cached financials, not a winner call.
Accenture plc (ACN) is a information technology services company listed on US.
Palisade Bio Inc (PALI) is a biotechnology company listed on NASDAQ.
Latest reported ACN revenue for 2025-08-31 was $17.60B. Net income was $1.41B. Revenue was down 0.7% from 2025-05-31 to 2025-08-31. ACN currently screens at market cap $186.16B and trailing P/E 23.8.
Latest reported PALI revenue for 2026-06-30 was $500.0K. Net income was -$20.2M. PALI currently screens at market cap $316.3M and trailing P/E 15.2.
ACN currently screens at market cap $186.16B and trailing P/E 23.8. PALI currently screens at market cap $316.3M and trailing P/E 15.2.
Not investment advice. Open the ACN and PALI stock pages for the full models.
Not investment advice.